 |
James E. Barrett, Ph.D. is Professor of Pharmacology and Physiology at Drexel University School of Medicine. He received his Ph.D. from Pennsylvania State University and had postdoctoral training in behavioral neurobiology and neuropharmacology at the Worcester Foundation for Experimental Biology. He served on the faculty at the University of Maryland and was a Professor of Biopsychology. Before moving to the pharmaceutical industry, Dr. Barrett was a Professor of Psychiatry, Medical Psychology and Pharmacology at the Uniformed Services University of the Health Sciences in Bethesda, MD
Dr. Barrett joined Wyeth in 1995 following the merger with Lederle Laboratories where he had been Director of Central Nervous System Research for three years. At Wyeth, Dr. Barrett was Vice President of Neuroscience. Dr. Barrett has extensive experience in the identification of targets and drug development in neurodegenerative and neurological diseases and in neuropsychiatric disorders. He left Wyeth to join Memory Pharmaceuticals as Sr. VP of R & D. Prior to his current position at Drexel University, he was Sr. Vice President of Research and Development, Chief Scientific office and President, Research at Adolor Corporation, Exton, PA. He has over 275 published scientific articles, books and abstracts and is a member of seven editorial boards. He is Past President of the American Society for Pharmacology and Experimental Therapeutics.
|
